{"id":"NCT02219503","sponsor":"AbbVie","briefTitle":"A Study to Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir in Adults With Genotype 1b Chronic Hepatitis C Virus (HCV) Infection and Cirrhosis","officialTitle":"An Open-Label, Single-Arm Study to Evaluate the Safety and Efficacy of Ombitasvir/ABT-450/Ritonavir and Dasabuvir in Adults With Genotype 1b Chronic Hepatitis C Virus (HCV) Infection and Cirrhosis (TURQUOISE-III)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2014-09","primaryCompletion":"2015-06","completion":"2015-09","firstPosted":"2014-08-19","resultsPosted":"2016-06-29","lastUpdate":"2021-07-12"},"enrollment":60,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Chronic Hepatitis C Infection","Compensated Cirrhosis"],"interventions":[{"type":"DRUG","name":"Ombitasvir/Paritaprevir/Ritonavir","otherNames":["ABT-267 also known as ombitasvir","ABT-450 also known as paritaprevir","Ritonavir also known as norvir"]},{"type":"DRUG","name":"Dasabuvir","otherNames":["ABT-333"]}],"arms":[{"label":"Ombitasvir/Paritaprevir/Ritonavir plus Dasabuvir","type":"EXPERIMENTAL"}],"summary":"The purpose of this study was to evaluate the safety and efficacy of ombitasvir/ paritaprevir/ ritonavir and dasabuvir in adults with genotype 1b chronic hepatitis C virus (HCV) infection and cirrhosis.","primaryOutcome":{"measure":"Percentage of Participants With Sustained Virologic Response 12 Weeks (SVR12) Post-treatment","timeFrame":"Post-treatment Day 1 to Post-treatment Week 12","effectByArm":[{"arm":"Ombitasvir/Paritaprevir/Ritonavir Plus Dasabuvir","deltaMin":100,"sd":null}],"pValues":[{"comp":"OG000","p":null},{"comp":"OG000","p":null}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":["26476290"],"seeAlso":["http://www.rxabbvie.com/"]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":60},"commonTop":["FATIGUE","DIARRHOEA","HEADACHE","ARTHRALGIA","DIZZINESS"]}}